OKYO Pharma Limited (NasdaqCM: OKYO)
Health Care · Biotechnology · GB
$1.38
-6.12% today · -27.9% 1Y
OKYO Pharma Limited (NasdaqCM: OKYO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $77.14M and employs 5 people.
Over the last twelve months the share price has lost 27.9%, trading between 1.26 and 3.20.
Tweenvest scores OKYO Pharma Limited across four factors: quality 35/100, value 74/100. Its strongest factor is value.
OKYO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $77.14M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- -0.06
- 52-week high
- $3.20
- 52-week low
- $1.26
- Avg volume (3M)
- —
- Shares outstanding
- 52.48M
- Employees
- 5
- Next earnings
- —
About OKYO Pharma Limited
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine adrenal medulla lipidated-peptide analogue, intended to treat neuropathic ocular pain. Established in 2007, OKYO Pharma Limited maintains its headquarters in London, UK.
- ISIN
- GG00BMFG5F62
- Founded
- 2007
- Listed since
- May 17, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wuhan YZY Biopharma Co., Ltd.SEHK: 2496 | $78.80M | HK$3.19 | -0.31% |
| Nordicus Partners CorporationOTCPK: NORD | $77.95M | $4.01 | +13.89% |
| ABIONYX Pharma SAENXTPA: ABNX | $77.29M | €1.62 | -8.88% |
| PDS Biotechnology CorporationNasdaqCM: PDSB | $77.19M | $1.08 | +0.94% |
| Covalon Technologies Ltd.TSXV: COV | $77.11M | CA$3.98 | 0.00% |
| Sensorion SAENXTPA: ALSEN | $76.66M | €5.90 | -10.74% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $76.25M | ₩2,315.00 | +8.94% |
| MedPacto, Inc.KOSDAQ: A235980 | $75.59M | ₩2,970.00 | +5.88% |
Figures last refreshed Oct 4, 2026.